Glaxo plays down Bristol link
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.GLAXO WELLCOME yesterday played down speculation of a pounds 140bn merger with US drugs rival Bristol Myers Squibb, but said it still wanted to link up with a competitor.
Sources close to Glaxo said the UK company held informal talks over a no-premium merger with BMS, the world's fifth-largest drug maker, but negotiations broke down a few months ago and are unlikely to be resumed. Glaxo is also thought to have considered and rejected a merger with Roche of Switzerland.
The BMS failure raises the pressure on Glaxo and SmithKline Beecham to reopen talks on their own merger. Jan Leschly, SKB chief executive, has since scotched suggestions that a deal may still be on.
However, Sir Richard Sykes, Glaxo chairman, believes the logic of further consolidation is irrefutable and is keen to find a partner. His target is for Glaxo to control 10 per cent of the world drug market. It currently has a 4 per cent share.
A merger with BMS would have produced a group with a combined share of 8 per cent and market value of pounds 140bn.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments